Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 20/20 | 0.65 |
| ▸ | CTSK | P43235 | 5/20 | 0.65 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28989788 | 1.00 | CTSC (0.65) | CTSCCTSKKCNH2 | |
| SCHEMBL25146673 | 1.00 | CTSC (0.65) | CTSCCTSKKCNH2 | |
| SCHEMBL24981836 | 1.00 | CTSC (0.65) | CTSCCTSKKCNH2 | |
| SCHEMBL25146421 | 1.00 | CTSC (0.65) | CTSCCTSKKCNH2 | |
| SCHEMBL31758515 | 0.89 | CTSC (0.70) | CTSCKCNH2 | |
| SCHEMBL24982371 | 0.89 | CTSC (0.64) | CTSCCTSKKCNH2 | |
| SCHEMBL29455603 | 0.89 | CTSC (0.64) | CTSCCTSKKCNH2 | |
| SCHEMBL28989501 | 0.89 | CTSC (0.64) | CTSCCTSKKCNH2 | |
| SCHEMBL28989500 | 0.89 | CTSC (0.64) | CTSCCTSKKCNH2 | |
| SCHEMBL25865701 | 0.88 | CTSC (0.65) | CTSCCTSKKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4665717-A2 | USES OF CERTAIN 1,4-OXAZEPANE-2-CARBOXAMIDES AS DPP1 INHIBITORS | Insmed Incorporated (US) | 2025-12-24 | — | — | EP | disclosed |
| WO-2024173556-A2 | USES OF CERTAIN 1,4-OXAZEPANE-2-CARBOXAMIDES AS DPP1 INHIBITORS | INSMED INCORPORATED (US) | 2024-08-22 | — | — | WO | disclosed |
| WO-2022042591-A1 | NITRILE DERIVATIVE THAT ACTS AS INHIBITOR OF DIPEPTIDYL PEPTIDASE 1 AND USE THEREOF | 四川海思科制药有限公司 | 2022-03-03 | — | — | WO | disclosed |